Value of selective chemoembolization in the treatment of hepatic metastases in colorectal carcinoma

Figure 1 Actuarial survival after chemoembolization for large intestinal liver metastases of the 40 patients.

Figure 2 There was significant difference in survival between cirrhotic patients with class A and B (P < 0. 01).

Figure 3 Median survival by site of metastases of patients with metastatic disease limited to the liver (n = 28) and of patients with more extensive disease (n = 12) was 14 and 3 mo, respectively (P < 0. 02).